[시장보고서]콜레스테롤 검사 제품 및 서비스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 검사별, 연령층별, 용도별, 서비스 프로바이더별, 지역별, 부문 예측(2025-2030년)

콜레스테롤 검사 제품 및 서비스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 검사별, 연령층별, 용도별, 서비스 프로바이더별, 지역별, 부문 예측(2025-2030년)

Cholesterol Testing Products And Services Market Size, Share & Trends Analysis Report By Product (Testing Kits, Testing Strips), By Test, By Age Group, By Application, By Service Provider, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1609965

리서치사 : Grand View Research

발행일 : 2024년 11월

페이지 정보 : 영문 100 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,675,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,133,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,049,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

콜레스테롤 검사 제품·서비스 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 콜레스테롤 검사 제품·서비스 시장 규모는 2025-2030년 8.4%의 CAGR을 기록하며, 2030년까지는 319억 8,000만 달러에 달할 전망입니다. 운동 부족은 콜레스테롤 수치 상승과 비만, 당뇨병, 심혈관 질환과 같은 다른 증상을 유발할 수 있습니다. 이러한 요인은 가까운 미래에 콜레스테롤 검사 제품 및 서비스에 대한 수요를 촉진할 것으로 예상됩니다.

흡연, 고혈압, 비만과 같은 다른 위험 요소와 더불어 고혈중 콜레스테롤 수치를 조절해야 할 필요성이 증가하고 있습니다. Journal of the American Medical Association(JAMA)에 따르면 1999-2016년까지 미국 청소년의 콜레스테롤 수치가 개선되었지만, 이상적인 콜레스테롤 수치 범위에 속하는 청소년과 어린이는 50%에 불과한 것으로 나타났습니다. 범위에 있는 청소년과 어린이는 50%에 불과하며, 그 중 25%는 임상적으로 높은 범위에 속합니다.

Journal of the American College of Cardiology에 따르면 2018년 미국 성인 중 3,100만 명이 총 콜레스테롤 수치가 높았으며, 그 중 약 1/3은 저밀도 지단백(LDL) 수치가 높은 것으로 나타났습니다. 미국내 과체중 인구 증가는 콜레스테롤 검사 제품 및 서비스에 대한 수요를 촉진하는 또 다른 요인입니다. 노인 인구 증가는 시장 성장을 가속하는 중요한 요인 중 하나입니다. 이 그룹의 인구는 뇌졸중, 심장마비 등 다양한 심혈관 질환에 걸리기 쉽습니다. 따라서 콜레스테롤 수치의 상승은 고령화 인구의 실질적인 위험 요소이며, 이는 제품 수요를 촉진할 것으로 예상됩니다.

콜레스테롤 검사 제품 및 서비스 시장 보고서 및 하이라이트

검사 키트는 2024년 45.8%의 점유율을 차지하며 시장을 주도했습니다. 검사 키트는 편리함과 사용 편의성을 제공하여 개인이 검사실을 방문하지 않고도 집에서 검사를 수행할 수 있도록 합니다.
총 콜레스테롤 검사는 2024년 38.6%의 매출 점유율로 시장을 장악했습니다. 총 콜레스테롤 검사는 고밀도 지단백(HDL), LDL, 중성지방을 포함한 개인의 콜레스테롤 수치를 철저하게 평가합니다.
고령자 부문은 노년층의 고콜레스테롤 및 심혈관 질환(CVDs) 유병률 증가에 힘입어 2024년 46.9%의 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
심혈관 질환은 전 세계 사망률의 주요 원인인 CVD의 발병률 증가에 힘입어 2024년 35.5%의 매출 점유율로 시장을 주도했습니다.
병원 및 클리닉이 시장을 장악하고 있으며, 2024년 39.1%의 점유율을 차지할 것으로 예상됩니다. 이들 시설은 첨단 진단 기술을 활용하고 숙련된 전문가가 상주하고 있으며, 정확하고 효율적인 콜레스테롤 검사를 할 수 있습니다.

테스트 시장 점유율, 2024년·2030년
테스트 부문 대시보드
시장 규모·예측과 동향 분석, 테스트별, 2018-2030년
총콜레스테롤 검사
HDL(High Density Lipoprotein) 콜레스테롤 검사
LDL(Low Density Lipoprotein) 콜레스테롤 검사
트리글리세리드 검사
기타

제6장 콜레스테롤 검사 제품·서비스 시장 : 연령층 비즈니스 분석

연령층 시장 점유율, 2024년·2030년
연령층 부문 대시보드
시장 규모·예측과 동향 분석, 연령층별, 2018-2030년
고령자
성인
소아

제7장 콜레스테롤 검사 제품·서비스 시장 : 용도 비즈니스 분석

용도 시장 점유율, 2024년·2030년
용도 부문 대시보드
시장 규모·예측과 동향 분석, 용도별, 2018-2030년
심혈관질환
당뇨병
비만
고지혈증
기타

제8장 콜레스테롤 검사 제품·서비스 시장 : 서비스 프로바이더 비즈니스 분석

서비스 프로바이더 시장 점유율, 2024년·2030년
서비스 프로바이더 부문 대시보드
시장 규모·예측과 동향 분석, 서비스 프로바이더별, 2018-2030년
병원·진료소
진단 검사실
외래 진료 센터
기타

제9장 콜레스테롤 검사 제품·서비스 시장 : 제품별, 검사별, 연령층별, 용도별, 서비스 프로바이더별 지역 추정·동향 분석

지역별 시장 점유율 분석, 2024년·2030년
지역 시장 대시보드
시장 규모·예측 동향 분석, 2018-2030년 :
북미
- 국가별, 2018-2030년
- 미국
- 캐나다
- 멕시코
유럽
- 국가별, 2018-2030년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 덴마크
- 스웨덴
아시아태평양
- 국가별, 2018-2030년
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 국가별, 2018-2030년
- 브라질
- 아르헨티나
중동 및 아프리카
- 국가별, 2018-2030년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제10장 경쟁 구도

참가자 개요
기업의 시장 현황 분석
기업 분류
전략 지도제작
기업 개요/리스트
- Quest Diagnostics Incorporated
- Eurofins Scientific
- Spectra Laboratories, Inc.(Fresenius Medical Care)
- Novartis AG
- Cell Biolabs, Inc.
- Randox Laboratories Ltd.
- SYNLAB AG
- BioReference Health, LLC
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Inc.
- Clinical Reference Laboratory, Inc.
- Elabscience Bionovation Inc.

KSA

영문 목차

영문목차

Cholesterol Testing Products And Services Market Growth & Trends:

The global cholesterol testing products and services market size is expected to reach USD 31.98 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Insufficient physical activity leads to high cholesterol levels and other conditions, such as obesity, diabetes, and cardiovascular diseases. This factor is anticipated to drive the demand for cholesterol testing products and services in near future.

There is an increased need to control high blood cholesterol levels, in addition to other risk factors such as smoking, high blood pressure, and obesity. This has led to high adoption of diagnostic tools and services. According to the Journal of the American Medical Association (JAMA), while the cholesterol levels in the U.S. youth have improved from 1999 to 2016, only 50% of adolescents and children have the ideal cholesterol range and 25% of them are in the clinically high range.

According to the Journal of the American College of Cardiology, in 2018, 31 million of the U.S. adults had high total cholesterol and around one-third of them had high levels of Low-Density Lipoprotein (LDL). Growing number of people being overweight in U.S. is another factor driving the demand for cholesterol testing products and services. Increasing geriatric population is one of the significant factors driving the market growth. This group of population is prone to various cardiovascular diseases such as stroke and heart attack. Thus, increasing cholesterol level is a substantial risk factor for the aging population, which is expected to drive the product demand.

Cholesterol Testing Products And Services Market Report Highlights:

Testing kits led the market and accounted for a share of 45.8% in 2024. Testing kits provide convenience and user-friendliness, enabling individuals to perform tests at home without laboratory visits.
Total cholesterol tests dominated the market with a revenue share of 38.6% in 2024. Total cholesterol tests offer a thorough evaluation of an individual's cholesterol levels, including high density lipoprotein (HDL), LDL, and triglycerides.
The geriatric segment held the largest revenue share of 46.9% in 2024, aided by the rising prevalence of high cholesterol and cardiovascular diseases (CVDs) among older adults.
Cardiovascular diseases led the market with a revenue share of 35.5% in 2024, supported by the rising incidence of CVDs, a leading cause of global mortality.
Hospitals and clinics dominated the market, accounting for a share of 39.1% in 2024. These facilities utilize advanced diagnostic technologies and are staffed by trained professionals to ensure accurate and efficient cholesterol testing.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Test
- 1.2.3. Age Group
- 1.2.4. Application
- 1.2.5. Service Provider
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Cholesterol Testing Products And Services Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Cholesterol Testing Products And Services Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Testing Kits
- 4.4.1. Testing Kits Market, 2018 - 2030 (USD Million)
4.5. Testing Strips
- 4.5.1. Testing Strips Market, 2018 - 2030 (USD Million)
4.6. Others
- 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Cholesterol Testing Products And Services Market: Test Business Analysis

5.1. Test Market Share, 2024 & 2030
5.2. Test Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Test, 2018 to 2030 (USD Million)
5.4. Total Cholesterol Tests
- 5.4.1. Total Cholesterol Tests Market, 2018 - 2030 (USD Million)
5.5. High Density Lipoprotein (HDL) Cholesterol Tests
- 5.5.1. High Density Lipoprotein (HDL) Cholesterol Tests Market, 2018 - 2030 (USD Million)
5.6. Low Density Lipoprotein (LDL) Cholesterol Tests
- 5.6.1. Low Density Lipoprotein (LDL) Cholesterol Tests Market, 2018 - 2030 (USD Million)
5.7. Triglyceride Tests
- 5.7.1. Triglyceride Tests Market, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Cholesterol Testing Products And Services Market: Age Group Business Analysis

6.1. Age Group Market Share, 2024 & 2030
6.2. Age Group Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
6.4. Geriatric
- 6.4.1. Geriatric Market, 2018 - 2030 (USD Million)
6.5. Adult
- 6.5.1. Adult Market, 2018 - 2030 (USD Million)
6.6. Pediatric
- 6.6.1. Pediatric Market, 2018 - 2030 (USD Million)

Chapter 7. Cholesterol Testing Products And Services Market: Application Business Analysis

7.1. Application Market Share, 2024 & 2030
7.2. Application Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Cardiovascular Diseases
- 7.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
7.5. Diabetes
- 7.5.1. Diabetes Market, 2018 - 2030 (USD Million)
7.6. Obesity
- 7.6.1. Obesity Market, 2018 - 2030 (USD Million)
7.7. Hyperlipidemia
- 7.7.1. Hyperlipidemia Market, 2018 - 2030 (USD Million)
7.8. Others
- 7.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Cholesterol Testing Products And Services Market: Service Provider Business Analysis

8.1. Service Provider Market Share, 2024 & 2030
8.2. Service Provider Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Service Provider, 2018 to 2030 (USD Million)
8.4. Hospitals and Clinics
- 8.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
8.5. Diagnostic Laboratories
- 8.5.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
8.6. Ambulatory Care Centers
- 8.6.1. Ambulatory Care Centers Market, 2018 - 2030 (USD Million)
8.7. Others
- 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Cholesterol Testing Products And Services Market: Regional Estimates & Trend Analysis by Product, Test, Age Group, Application, and Service Provider

9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
- 9.4.1. North America Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.4.2. U.S.
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Regulatory Framework
  - 9.4.2.3. Competitive Insights
  - 9.4.2.4. U.S. Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Canada
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Regulatory Framework
  - 9.4.3.3. Competitive Insights
  - 9.4.3.4. Canada Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. Mexico
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Regulatory Framework
  - 9.4.4.3. Competitive Insights
  - 9.4.4.4. Mexico Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5. Europe
- 9.5.1. Europe Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.5.2. UK
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Regulatory Framework
  - 9.5.2.3. Competitive Insights
  - 9.5.2.4. UK Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Germany
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Regulatory Framework
  - 9.5.3.3. Competitive Insights
  - 9.5.3.4. Germany Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. France
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Regulatory Framework
  - 9.5.4.3. Competitive Insights
  - 9.5.4.4. France Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Italy
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Regulatory Framework
  - 9.5.5.3. Competitive Insights
  - 9.5.5.4. Italy Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Spain
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Regulatory Framework
  - 9.5.6.3. Competitive Insights
  - 9.5.6.4. Spain Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Norway
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Regulatory Framework
  - 9.5.7.3. Competitive Insights
  - 9.5.7.4. Norway Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.8. Denmark
  - 9.5.8.1. Key Country Dynamics
  - 9.5.8.2. Regulatory Framework
  - 9.5.8.3. Competitive Insights
  - 9.5.8.4. Denmark Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.9. Sweden
  - 9.5.9.1. Key Country Dynamics
  - 9.5.9.2. Regulatory Framework
  - 9.5.9.3. Competitive Insights
  - 9.5.9.4. Sweden Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
- 9.6.1. Asia Pacific Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.6.2. Japan
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Regulatory Framework
  - 9.6.2.3. Competitive Insights
  - 9.6.2.4. Japan Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. China
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Regulatory Framework
  - 9.6.3.3. Competitive Insights
  - 9.6.3.4. China Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. India
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Regulatory Framework
  - 9.6.4.3. Competitive Insights
  - 9.6.4.4. India Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. South Korea
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Regulatory Framework
  - 9.6.5.3. Competitive Insights
  - 9.6.5.4. South Korea Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.6. Australia
  - 9.6.6.1. Key Country Dynamics
  - 9.6.6.2. Regulatory Framework
  - 9.6.6.3. Competitive Insights
  - 9.6.6.4. Australia Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Thailand
  - 9.6.7.1. Key Country Dynamics
  - 9.6.7.2. Regulatory Framework
  - 9.6.7.3. Competitive Insights
  - 9.6.7.4. Thailand Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
- 9.7.1. Latin America Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.7.2. Brazil
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Regulatory Framework
  - 9.7.2.3. Competitive Insights
  - 9.7.2.4. Brazil Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Argentina
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Regulatory Framework
  - 9.7.3.3. Competitive Insights
  - 9.7.3.4. Argentina Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8. MEA
- 9.8.1. MEA Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.8.2. South Africa
  - 9.8.2.1. Key Country Dynamics
  - 9.8.2.2. Regulatory Framework
  - 9.8.2.3. Competitive Insights
  - 9.8.2.4. South Africa Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key Country Dynamics
  - 9.8.3.2. Regulatory Framework
  - 9.8.3.3. Competitive Insights
  - 9.8.3.4. Saudi Arabia Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.4. UAE
  - 9.8.4.1. Key Country Dynamics
  - 9.8.4.2. Regulatory Framework
  - 9.8.4.3. Competitive Insights
  - 9.8.4.4. UAE Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.5. Kuwait
  - 9.8.5.1. Key Country Dynamics
  - 9.8.5.2. Regulatory Framework
  - 9.8.5.3. Competitive Insights
  - 9.8.5.4. Kuwait Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
- 10.5.1. Quest Diagnostics Incorporated
  - 10.5.1.1. Overview
  - 10.5.1.2. Financial Performance
  - 10.5.1.3. Product Benchmarking
  - 10.5.1.4. Strategic Initiatives
- 10.5.2. Eurofins Scientific
  - 10.5.2.1. Overview
  - 10.5.2.2. Financial Performance
  - 10.5.2.3. Product Benchmarking
  - 10.5.2.4. Strategic Initiatives
- 10.5.3. Spectra Laboratories, Inc. (Fresenius Medical Care)
  - 10.5.3.1. Overview
  - 10.5.3.2. Financial Performance
  - 10.5.3.3. Product Benchmarking
  - 10.5.3.4. Strategic Initiatives
- 10.5.4. Novartis AG
  - 10.5.4.1. Overview
  - 10.5.4.2. Financial Performance
  - 10.5.4.3. Product Benchmarking
  - 10.5.4.4. Strategic Initiatives
- 10.5.5. Cell Biolabs, Inc.
  - 10.5.5.1. Overview
  - 10.5.5.2. Financial Performance
  - 10.5.5.3. Product Benchmarking
  - 10.5.5.4. Strategic Initiatives
- 10.5.6. Randox Laboratories Ltd.
  - 10.5.6.1. Overview
  - 10.5.6.2. Financial Performance
  - 10.5.6.3. Product Benchmarking
  - 10.5.6.4. Strategic Initiatives
- 10.5.7. SYNLAB AG
  - 10.5.7.1. Overview
  - 10.5.7.2. Financial Performance
  - 10.5.7.3. Product Benchmarking
  - 10.5.7.4. Strategic Initiatives
- 10.5.8. BioReference Health, LLC
  - 10.5.8.1. Overview
  - 10.5.8.2. Financial Performance
  - 10.5.8.3. Product Benchmarking
  - 10.5.8.4. Strategic Initiatives
- 10.5.9. Laboratory Corporation of America Holdings
  - 10.5.9.1. Overview
  - 10.5.9.2. Financial Performance
  - 10.5.9.3. Product Benchmarking
  - 10.5.9.4. Strategic Initiatives
- 10.5.10. Thermo Fisher Scientific Inc.
  - 10.5.10.1. Overview
  - 10.5.10.2. Financial Performance
  - 10.5.10.3. Product Benchmarking
  - 10.5.10.4. Strategic Initiatives
- 10.5.11. Clinical Reference Laboratory, Inc.
  - 10.5.11.1. Overview
  - 10.5.11.2. Financial Performance
  - 10.5.11.3. Product Benchmarking
  - 10.5.11.4. Strategic Initiatives
- 10.5.12. Elabscience Bionovation Inc.
  - 10.5.12.1. Overview
  - 10.5.12.2. Financial Performance
  - 10.5.12.3. Product Benchmarking
  - 10.5.12.4. Strategic Initiatives